Skip to content

Ausgewählte Veröffentlichungen mit Peer-Review

 

Journal image

 

Klinische Ergebnisse der Studie SONATA Pivotal IDE:

Chudnoff S, Guido R, Roy K, Levine D, Mihalov L, Garza-Leal JG. Ultrasound-Guided Transcervical Ablation of Uterine Leiomyomas. Obstet Gynecol. 2019 Jan; 133(1): 13-22

ANZEIGEN

 

 

ANZEIGEN Garza-Leal JG. Long-Term Clinical Outcomes of Transcervical Radiofrequency Ablation of Uterine Fibroids: The VITALITY Study. Journal of Gynecologic Surgery. 2019; 35:19-23. 

ANZEIGEN Brölmann H, Bongers M, Garza-Leal J, Gupta J, et al. The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids. Gynecol Surg. 2016; 13: 27-35.

ANZEIGEN Taheri M, Galo L, Potts C, Sakhel K, Quinn SD. Nonresective treatments for uterine fibroids: a systematic review of uterine and fibroid volume reductions. International Journal of Hyperthermia. 2019; 1-7.

ANZEIGEN Huirne J, Brooks E. Improvement in health utility after transcervical radiofrequency ablation of uterine fibroids with the Sonata System: Health utility after radiofrequency ablation. Eur J Obstet Gynecol Reprod Biol. 2018; 224: 175-180.

ANZEIGEN Toub, DB. A New Paradigm for Uterine Fibroid Treatment: Transcervical, Intrauterine Sonography-Guided Radiofrequency Ablation of Uterine Fibroids with the Sonata System. Curr Obstet Gynecol Rep. 2017;6(1):67-73.

ANZEIGEN Bongers M, Brölmann H, Gupta J, Garza-Leal JG, Toub D. Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate® System: three- and six-month endpoint results from the FAST-EU study. Gynecol Surg. 2015;12(1):61-70.

ANZEIGEN Jones, S., O’Donovan, P, Toub, D. Radiofrequency ablation for treatment of symptomatic uterine fibroids. Obstet Gynecol Int.2012; 2012:194839.

ANZEIGEN Garza-Leal, JG, Toub, D, León, IH, et al. Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate System: safety, tolerability, and ablation results in a closed abdomen setting. Gynecol Surg (2011) 8: 327.